UA93254C2 - Способ получения препарата инсулина для перорального применения - Google Patents

Способ получения препарата инсулина для перорального применения

Info

Publication number
UA93254C2
UA93254C2 UAA200900222A UAA200900222A UA93254C2 UA 93254 C2 UA93254 C2 UA 93254C2 UA A200900222 A UAA200900222 A UA A200900222A UA A200900222 A UAA200900222 A UA A200900222A UA 93254 C2 UA93254 C2 UA 93254C2
Authority
UA
Ukraine
Prior art keywords
insulin preparation
ranges
producing insulin
insulin
peroral use
Prior art date
Application number
UAA200900222A
Other languages
English (en)
Ukrainian (uk)
Inventor
Андрей Владимирович Артамонов
Петр Иванович Родионов
Original Assignee
Общество C Ограниченной Ответственностью "Концерн 03"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество C Ограниченной Ответственностью "Концерн 03" filed Critical Общество C Ограниченной Ответственностью "Концерн 03"
Publication of UA93254C2 publication Critical patent/UA93254C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
UAA200900222A 2006-09-13 2007-11-09 Способ получения препарата инсулина для перорального применения UA93254C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006132763/15A RU2316339C1 (ru) 2006-09-13 2006-09-13 Способ получения препарата инсулина для перорального применения

Publications (1)

Publication Number Publication Date
UA93254C2 true UA93254C2 (ru) 2011-01-25

Family

ID=39184228

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200900222A UA93254C2 (ru) 2006-09-13 2007-11-09 Способ получения препарата инсулина для перорального применения

Country Status (13)

Country Link
US (1) US20090312235A1 (ru)
EP (1) EP2067484A4 (ru)
JP (1) JP2010503665A (ru)
CN (1) CN101384276A (ru)
AU (1) AU2007295132A1 (ru)
CA (1) CA2662799A1 (ru)
EA (1) EA012884B1 (ru)
IL (1) IL197470A0 (ru)
MX (1) MX2009001286A (ru)
RU (1) RU2316339C1 (ru)
UA (1) UA93254C2 (ru)
WO (1) WO2008033058A2 (ru)
ZA (1) ZA200807272B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA90013C2 (ru) 2008-03-19 2010-03-25 Давид Анатолійович Нога Фармацевтическая композиция, содержащая инсулин, и способ его получения
RU2395296C1 (ru) * 2009-02-19 2010-07-27 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата проинсулина для перорального применения
RU2413531C2 (ru) * 2009-03-31 2011-03-10 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата с-пептида проинсулина для перорального применения
RU2441036C1 (ru) * 2010-09-30 2012-01-27 Общество с ограниченной ответственностью Научно-производственное объединение "Перспектива" (ООО НПО "Перспектива") Способ получения активированного полиэтиленоксида
RU2452509C1 (ru) * 2011-01-31 2012-06-10 Общество с ограниченной ответственностью "Саентифик Фьючер Менеджмент" ООО "Саентифик Фьючер Менеджмент" Средство для стимуляции роста организма
SG11201403207WA (en) * 2011-12-12 2014-09-26 Melior Pharmaceuticals I Inc Treatment of type i and type ii diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066551C1 (ru) * 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
RU2117488C1 (ru) * 1997-07-30 1998-08-20 Институт нефтехимического синтеза им.А.В.Топчиева РАН Твердое инсулинсодержащее лекарственное средство
RU2213557C2 (ru) * 2001-12-26 2003-10-10 Закрытое акционерное общество "Аксис" Фармацевтическая композиция, обладающая тромболитическими, противовоспалительными и цитопротективными свойствами

Also Published As

Publication number Publication date
JP2010503665A (ja) 2010-02-04
ZA200807272B (en) 2009-07-29
US20090312235A1 (en) 2009-12-17
RU2316339C1 (ru) 2008-02-10
EP2067484A4 (de) 2009-10-28
WO2008033058A3 (en) 2008-05-08
EA200801259A1 (ru) 2008-08-29
CA2662799A1 (en) 2008-03-20
AU2007295132A1 (en) 2008-03-20
EA012884B1 (ru) 2009-12-30
EP2067484A2 (de) 2009-06-10
IL197470A0 (en) 2011-08-01
CN101384276A (zh) 2009-03-11
WO2008033058A2 (en) 2008-03-20
MX2009001286A (es) 2009-03-20

Similar Documents

Publication Publication Date Title
EP1335661A4 (en) PREPARATION OF MICRO BEADS
EP3949969A3 (en) Benzazepine compounds, conjugates, and uses thereof
CY1118222T1 (el) Συνθεσεις λυασης φαινυλαλανινης αμμωνιας προκαρυωτικων και μεθοδοι αγωγης καρκινου χρησιμοποιωντας συνθεσεις εξ' αυτης
TW200732447A (en) Adhesive formulation, method for the production thereof, and use thereof
MX341883B (es) Composicion farmaceutica para el tratamiento y prevencion de canceres.
MY180713A (en) Modified antibody constant region
MX2020012679A (es) Compuestos de amino-pirazincarboxamida, conjugados, y usos de los mismos.
MX2010003443A (es) Metodo de modificacion del punto isoelectrico de anticuerpos medinate la sustitucion de aminoacidos en region de determinacion de complementariedad (cdr).
WO2007100902A3 (en) Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
PL410218A1 (pl) Sposób wytwarzania stabilnej liofilizowanej kompozycji obejmującej monomeryczne koniugaty pochodna kalicheamycyny/przeciwciało anty-CD22, kompozycja otrzymana tym sposobem oraz jej zastosowanie
WO2009104074A3 (en) Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
SG148997A1 (en) Powders comprising low molecular dextran and methods of producing those powders
UA101497C2 (ru) Конъюгаты фактора ix с увеличенным временем полужизни
TW200806315A (en) Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
PL1786400T3 (pl) Kompozycje farmaceutyczne do dostarczania biologicznie czynnych związków metodą kontrolowanego uwalniania
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
CA2518971A1 (en) Composition for administration of iron for the treatment of restless legs syndrome
WO2010122246A3 (fr) Procédé de formation d'émulsions à base de polymères de cyclodextrine et de composés lipophiles, émulsions ainsi obtenues, et compositions comprenant lesdites émulsions
WO2008033058A3 (en) Method for producing insulin in the form of an oral preparation
RU2012112839A (ru) Новая парентеральная композиция карбамазепина
MX2010006984A (es) Vacunas contra la malaria.
MX337358B (es) Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos.
TN2010000215A1 (en) Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof
FR2911608B1 (fr) Nouvelles compositions vaccinales anti paludique et ses utilisations.